Kirby mcinerney llp announces an investigation of shareholder claims on behalf of amryt pharma plc (amyt) investors

New york--(business wire)---- $amyt--the law firm of kirby mcinerney llp is investigating potential claims against amryt pharma plc (“amryt pharma” or the “company”) (nasdaq: amyt). the investigation concerns whether amryt pharma has violated the federal securities laws and/or engaged in other unlawful business practices. amryt pharma operates as a biopharmaceutical company. the company develops and delivers treatments for rare and orphan diseases. on february 28, 2022, amryt pharma issued a press releas
AMYT Ratings Summary
AMYT Quant Ranking